Tempest Therapeutics, Inc. Common Stock (TPST)
Tempest Therapeutics, Inc. Common Stock
XNAS:TPST
3.12
$3.14 - 217.00
$3.07 - 10.00
$3.09
$3.22
$3.11
$3.2
13.65
3.01
57990
361175.9
4583633.48
Chart
TendieTensor AI Analysis
Company
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.
Fundamentals
5
-0.320000
2.238970
-0.79
100
BBG002NDK339
BBG002NDK348
4.44M
4.44M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own TPST. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.